期刊文献+

多发性肌炎/皮肌炎伴发的间质性肺病相关血清学标志物 被引量:1

原文传递
导出
摘要 间质性肺病(interstitial lung disease,ILD)是影响PM/DM预后的重要因素.PM/DM-ILD早期启动免疫抑制剂治疗可明显改善预后,因此提前预测ILD或早期诊断预后不良的ILD至关重要.常规监测ILD的指标肺功能及胸部高分辨率CT(HRCT)检查有助于ILD的诊断及分型,但肺功能检查结果受多种因素影响,而HRCT使患者反复暴露于X线下不利于随访监测,且两者均不具有早期诊断价值,如抗黑色素瘤分化相关基因5 (melanoma differentiation-associated gene 5,MDA5)抗体阳性的快速进展的ILD (RP-ILD),患者在短期内即可导致呼吸衰竭、死亡.因此寻找更简便易行、易于为患者接受的预测PM/DM-ILD的指标对于改善预后具有重要意义.
作者 蒋真 李向培
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2014年第6期422-425,共4页 Chinese Journal of Rheumatology
基金 安徽省科技厅项目(12070403052)
  • 相关文献

参考文献21

  • 1Maldonado F, Patel RR, Iyer VN, et al. Are respiratory compli- cations common causes of death in inflammatory myopathies: an autopsy study?[J]. Respirology, 2012, 17: 455-460.
  • 2Koga T, Fujikawa K, Horai Y,et al. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM [J]. Rheumatology (Oxford), 2012, 51: 1278-1284.
  • 3Mimori T, Nakashima R, Hosono Y. Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment [J]. Curr Rheumatol Rep, 2012, 14: 264-274.
  • 4Hervier B, Wallaert B, Hachulla E, et al. Clinical manifesta- tions of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases[J]. Rheumatology (Oxford), 2010, 49: 972-976.
  • 5Selva-O'Callaghan A, Labrador-Horrillo M, Munoz-Gall X, et al. Polymyositis/dennatomyositis-associated lung disease: analysis of a series of 81 patients[J]. Lupus, 2005, 14: 534-542.
  • 6Mimori T, Nakashima R, Hosono Y. Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment [J]. Curr Rheumatol Rep, 2012, 14:264-274.
  • 7Howard OM, Dong HF, Yang D, et al. Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, acti- vate chemokine receptors on T lymphocytes and immature den- dritic cells[J]. J Exp Med, 2002, 196: 781-791.
  • 8袁凯,王国春,卢昕.炎性肌病特异性自身抗体研究进展[J].中华风湿病学杂志,2013,17(4):274-277. 被引量:5
  • 9Gono T, Sato S, Kawaguchi Y, et al. Anti-MDA5 antibody, fer-ritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody- positive dermatomyositis[J]. Rheumatology (Oxford), 2012, 51: 1563-1570.
  • 10Vanmcsa A, Csipo I, Nemeth J, et al. Characteristics of intersti- tial lung disease in SS-A positive/Jo-1 positive inflammatory my- opathy patients[J]. Rheumatol lnt, 2009, 29: 989-994.

二级参考文献38

  • 1卢昕,谢瑶,王国春.血清KL-6检测在特发性炎性肌病伴肺间质病变诊断中的价值[J].中华风湿病学杂志,2006,10(7):416-419. 被引量:16
  • 2Saketkoo LA, Ascherman DP, Cottin V, et al. Interstitial lung disease in idiopathic inflammatory myopathy. Curr Rheumatol Rev, 2010, 22:633-638.
  • 3Hermans C, Bernard A. Lung epithelium-specific proteins. Characteristics and potential applications as markers. Am J Respir Crit Care Med, 1999,159:646-678.
  • 4Ihn H, Asano Y, Kubo M, et al. Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/ dermato myositis: correlation with interstitial lung disease. Rheumatology, 2002, 41 : 1268-1272.
  • 5Marie I, Hachulla E, Cherin P, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum, 2002, 47: 614-622.
  • 6Kubo M, Ihn H, Yamane K, et al. Serum KL-6 in adult patients with polymyositis and dermatomyositis. Rheumatology, 2000, 39 : 632-636.
  • 7Ishii H, Mukae H, Kadota J, et al. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. Thorax, 2003,58:52-57.
  • 8Chmneos ZC, Chmneos ZS, Shepherd VL. Pulmonary Surfactant: An Immunological Perspective. Cell Physiol Biochem, 2010,25: 13-26.
  • 9Ohnishi H,Yokoyama A, Kondo K, et al. Comparative Study of KL-6, Surfaetant Protein-A, Surfaetant Protein-D, and Monocyte Chemoattractant Protein-1 as Serum Markers for Interstitial Lung Diseases. Am J Resp Crit Care, 2002, 165:378-381.
  • 10Kumtinovics G, Minier T, Radics J, et al. Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis. Clin Exp Rheumatol, 2008,26:414-420.

共引文献21

同被引文献2

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部